Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
27.18
-0.25 (-0.92%)
Jun 30, 2026, 4:00 PM EDT - Market closed
PBPH Holdings Information
PBPH is an equity ETF with a total of 56 individual holdings. The top holdings are Eli Lilly and Company stock at 16.17%, Johnson & Johnson at 9.69%, AbbVie at 7.00%, Merck & Co. at 4.98%, and Roche Holding AG at 4.52%.
Total Holdings
56
Top 10 Percentage
62.61%
Asset Class
Equity
ETF Category
Health
Assets
811.34M
PE Ratio
20.27
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 16.17% |
| 2 | JNJ | Johnson & Johnson | 9.69% |
| 3 | ABBV | AbbVie Inc. | 7.00% |
| 4 | MRK | Merck & Co., Inc. | 4.98% |
| 5 | SWX: ROP | Roche Holding AG | 4.52% |
| 6 | SWX: NOVN | Novartis AG | 4.43% |
| 7 | LON: AZN | AstraZeneca PLC | 4.32% |
| 8 | AMGN | Amgen Inc. | 4.31% |
| 9 | GILD | Gilead Sciences, Inc. | 3.64% |
| 10 | CPH: NOVO.B | Novo Nordisk A/S | 3.56% |
| 11 | PFE | Pfizer Inc. | 3.22% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.93% |
| 13 | BMY | Bristol-Myers Squibb Company | 2.77% |
| 14 | LON: GSK | GSK plc | 2.27% |
| 15 | EPA: SAN | Sanofi | 2.17% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.48% |
| 17 | EBR: ARGX | argenx SE | 1.29% |
| 18 | ETR: BAYN | Bayer Aktiengesellschaft | 1.20% |
| 19 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.15% |
| 20 | ASX: CSL | CSL Limited | 1.01% |
| 21 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.90% |
| 22 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.89% |
| 23 | SWX: SDZ | Sandoz Group AG | 0.86% |
| 24 | NTRA | Natera, Inc. | 0.85% |
| 25 | EBR: UCB | UCB SA | 0.84% |
As of Jun 29, 2026